Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7NW3

X-ray crystallographic study of PIYDIN, which contains the truncation determinants of binding PI and N, bound to RoAb13, a CCR5 antibody

Summary for 7NW3
Entry DOI10.2210/pdb7nw3/pdb
Related4S2S 7NJZ
DescriptorAntibody RoAb13 Heavy Chain, Antibody RoAb13 Light Chain, Region from C-C chemokine receptor type 5 N-terminal domain, ... (4 entities in total)
Functional Keywordsimmunoglobulin, anti-ccr5 antibody, epitope binding, immune system
Biological sourceMus musculus
More
Total number of polymer chains3
Total formula weight49256.92
Authors
Saridakis, E.,Helliwell, J.R.,Govada, L.,Chayen, N.E. (deposition date: 2021-03-16, release date: 2021-07-21, Last modification date: 2024-11-13)
Primary citationGovada, L.,Saridakis, E.,Kassen, S.C.,Bin-Ramzi, A.,Morgan, R.M.,Chain, B.,Helliwell, J.R.,Chayen, N.E.
X-ray crystallographic studies of RoAb13 bound to PIYDIN, a part of the N-terminal domain of C-C chemokine receptor 5.
Iucrj, 8:678-683, 2021
Cited by
PubMed Abstract: C-C chemokine receptor 5 (CCR5) is a major co-receptor molecule used by HIV-1 to enter cells. This led to the hypothesis that stimulating an antibody response would block HIV with minimal toxicity. Here, X-ray crystallographic studies of the anti-CCR5 antibody RoAb13 together with two peptides were undertaken: one peptide is a 31-residue peptide containing the PIYDIN sequence and the other is the PIDYIN peptide alone, where PIYDIN is part of the N-terminal region of CCR5 previously shown to be important for HIV entry. In the presence of the longer peptide (the complete N-terminal domain), difference electron density was observed at a site within a hypervariable CDR3 binding region. In the presence of the shorter core peptide PIYDIN, difference electron density is again observed at this CDR3 site, confirming consistent binding for both peptides. This may be useful in the design of a new biomimetic to stimulate an antibody response to CCR5 in order to block HIV infection.
PubMed: 34258015
DOI: 10.1107/S2052252521005340
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.20001097294 Å)
Structure validation

245663

数据于2025-12-03公开中

PDB statisticsPDBj update infoContact PDBjnumon